MYO16-AS1 was discovered to be expressed mainly in lung tissue and to be downregulated in LUAD; moreover, recent studies have reported the expression level of MYO16-AS1 in Parkinson's disease [19] and bladder cancer, but the regulatory mechanism has not been explored. This evidence concerns the gene MYO16 and urinary bladder carcinoma.